3/253/83433237 |
您所在的位置:网站首页 › 3/253/83433237 |
data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/32005089Considering gut microbiota in treatment of type 2 diabetes …网页2020年5月3日 · Advances in the understanding of the pathogenesis of type 2 diabetes mellitus (T2D) have revealed a role for gut microbiota dysbiosis in driving this disease. This suggests the possibility that approaches to restore a healthy host-microbiota relationship might be a means of ameliorating T2D. Indeed, recent studies indicate that many …
发布时间:2024-07-12data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/30759961Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool …网页2019年9月3日 · Affiliations 1 University of Sousse, Faculty of Medicine ‘Ibn el Jazzar’, Department of Physiology and Functional Explorations, Sousse, Tunisia; 2 Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Department of Pediatric Endocrinology, Paris, France; 3 Sorbonne Université, INSERM, Centre de Recherche St-Antoine UMR …
发布时间:2024-07-12data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/28678931Vascular Aging and Arterial Stiffness - PubMed网页Type 2 diabetes mellitus is an independent risk factor for SAH because it causes functional and structural damage to the arterial wall, leading to stiffness. Several studies have related oxidative stress, production of free radicals, and neuroendocrine and genetic changes to the physiopathogenesis of vascular aging.
发布时间:2024-07-12CopyRight 2018-2019 实验室设备网 版权所有 |